✦ LIBER ✦

High-Grade Transformation of Low-Grade Non-Hodgkin's Lymphomas: Mechanisms of Tumor Progression

✍ Scribed by Matolcsy, András

Book ID: 118157732
Publisher: Informa plc
Year: 1999
Tongue: English
Weight: 896 KB
Volume: 34
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428199909050950

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-grade non-hodgkin's lymphoma after h

Low-grade non-hodgkin's lymphoma after high-grade non-hodgkin's lymphoma in a child with ataxia teleangiectasia

✍ Ursula Schulte Overberg-Schmidt; Eckehard Baumgarten; Günter Henze; Rolf-Dieter 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 1 views

Low grade non-hodgkin's lymphoma after h

Low grade non-hodgkin's lymphoma after high grade non-hodgkin's lymphoma in a child with ataxia teleangiectasia

✍ Karl T. K. Chen; Ursula Schulte Overberg-Schmidt; GÜNter Henze 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 1 views

Follicular low-grade non-Hodgkin's lymph

Follicular low-grade non-Hodgkin's lymphoma: Long-term outcome with or without tumor progression

✍ Jens Ersbøll; Henrik B. Schultz; Jens Pedersen-Bjergaard; Nis I. Nissen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

Progressive loss of vision in patients w

Progressive loss of vision in patients with high-grade non-Hodgkin's lymphoma

✍ Harald Holte; Gunnar Saeter; Inger Marie S. Dahl; Arne Foss Abrahamsen 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB 👁 2 views

Acute tumor lysis syndrome in patients w

Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma

✍ Kenneth R. Hande; George C. Garrow 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 860 KB

Ifosfamide in the treatment of high-grad

Ifosfamide in the treatment of high-grade recurrent non-hodgkin's lymphomas

✍ Ian Magrath; Melissa Adde; John Sandlund; Vinay Jain 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB 👁 1 views

We report the results of two phase I1 trials of ifosfamide in very high risk patients with either partially responsive or recurrent non-Hodgkin's lymphomas. In the first study, in which patients were extremely heavily pretreated (50 per cent had received a very intensive salvage regimen containing v